| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | VCYT Veracyte, INC. | Leite John | Chief Commercial Officer-clia | Sell | 1,278 | $47.51 | $60,717.78 | -1.5% | - | - | |
| Dec 4, 2025 | VCYT Veracyte, INC. | McGuire Annie | SVP, General Counsel | Sell | 702 | $47.51 | $33,352.02 | -0.9% | - | - | |
| Dec 4, 2025 | VCYT Veracyte, INC. | Stapley Marc | Chief Executive Officer | Sell | 7,668 | $47.09 | $361,075.59 | -1.2% | - | - | |
| Dec 3, 2025 | SHC Sotera Health CO | Warburg Pincus & CO. | Director, 10% Owner | Sell | 9,720,000 | $16.33 | $158,727,600.00 | -22.2% | - | - | |
| Dec 3, 2025 | GRAL Grail, INC. | Ragusa Robert P | Chief Executive Officer | Sell | 40,000 | $95.24 | $3,809,534.92 | -1.4% | - | - | |
| Dec 3, 2025 | SHC Sotera Health CO | Warburg Pincus & CO. | Director, 10% Owner | Sell | 9,720,000 | $16.33 | $158,727,600.00 | -22.2% | - | - | |
| Dec 3, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 668 | $590.69 | $394,580.92 | -0.1% | - | - | |
| Dec 3, 2025 | GRAL Grail, INC. | Freidin Aaron | Chief Financial Officer | Sell | 25,000 | $99.15 | $2,478,817.50 | -8.8% | - | - | |
| Dec 3, 2025 | GRAL Grail, INC. | Ofman Joshua J. | President | Sell | 13,000 | $100.00 | $1,300,000.00 | -3.4% | - | - | |
| Dec 3, 2025 | SHC Sotera Health CO | Gtcr Investment XI LLC | Director, 10% Owner | Sell | 6,480,000 | $16.33 | $105,818,400.00 | -22.2% | - | - | |
| Dec 3, 2025 | TMO Thermo Fisher Scientific INC. | Lagarde Michel | Executive Vice President &COO | Sell | 62,000 | $582.68 | $36,126,126.38 | -27.6% | - | - | |
| Dec 2, 2025 | FLGT Fulgent Genetics, INC. | Xie Jian | President And COO | Sell | 1,140 | $28.33 | $32,298.25 | -0.3% | - | - | |
| Dec 2, 2025 | FLGT Fulgent Genetics, INC. | Gao Hanlin | Chief Scientific Officer | Sell | 1,075 | $28.33 | $30,456.69 | -0.1% | - | - | |
| Dec 2, 2025 | CSTL Castle Biosciences INC | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 2,678 | $39.23 | $105,057.94 | -6.4% | - | - | |
| Dec 2, 2025 | TMO Thermo Fisher Scientific INC. | Lowery Frederick M. | Executive Vice President | Sell | 6,912 | $581.94 | $4,022,369.28 | -32.5% | - | - | |
| Dec 2, 2025 | MEDP Medpace Holdings, INC. | Troendle August J. | CEO | Sell | 5,698 | $590.47 | $3,364,498.06 | -0.9% | - | - | |
| Dec 1, 2025 | NTRA Natera, INC. | Chapman Steven Leonard | CEO And President | Sell | 2,050 | $238.13 | $488,158.10 | -1.4% | - | - | |
| Dec 1, 2025 | WGS Genedx Holdings CORP. | Feeley Kevin | Chief Financial Officer | Sell | 377 | $162.54 | $61,276.07 | -8.2% | - | - | |
| Dec 1, 2025 | NTRA Natera, INC. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,527 | $238.24 | $363,796.76 | -1.4% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.